Zobrazeno 1 - 10
of 5 175
pro vyhledávání: '"tdm"'
Publikováno v:
TDM Berhad MarketLine Company Profile. 6/26/2023, p1-17. 17p.
Publikováno v:
TDM Berhad MarketLine Company Profile. 9/19/2022, p1-19. 19p.
Publikováno v:
TDM Berhad MarketLine Company Profile. 11/3/2021, p1-20. 20p.
Publikováno v:
TDM Berhad MarketLine Company Profile. 3/16/2020, p1-18. 18p.
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract This study systematically investigated four types of graphene quantum dots (GQDs) AHEX, ZTRI, ZHEX, and ATRI, and their interactions with glycine to form GQD-glycine complexes. Utilizing density functional theory (DFT) and the PM6 semiempiri
Externí odkaz:
https://doaj.org/article/da3f8d938c19407a9684baabf5a4def3
Publikováno v:
TDM Berhad MarketLine Company Profile. 5/22/2019, p1-18. 18p.
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3057-3071 (2024)
Lixia Li,1,* Xiaohui Huang,1,* Jingxian Liu,2,* Chao Li,1 Zhiyan Lin,1 Rongrong Ren,3 Yan Zhang,3 Haoshu Ding,3 Jihui Chen,1 Yanfei Mao3 1Department of Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai
Externí odkaz:
https://doaj.org/article/f35c7f945be34a0dae57f593336a489d
Autor:
Claire Roger
Publikováno v:
Journal of Intensive Medicine, Vol 4, Iss 3, Pp 287-298 (2024)
Effective treatment of sepsis not only demands prompt administration of appropriate antimicrobials but also requires precise dosing to enhance the likelihood of patient survival. Adequate dosing refers to the administration of doses that yield therap
Externí odkaz:
https://doaj.org/article/ef57d3bb7fb34eeda44309601cf25163
Autor:
Konrad Lewandowski, Agnieszka Karbownik, Andrzej Czyrski, Hanna Urjasz, Joanna Stanisławiak-Rudowicz, Edmund Grześkowiak, Edyta Szałek
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 81, Iss 2, Pp 263-278 (2024)
Olaparib, an oral poly-ADP ribose polymerase (PARP) inhibitor, is a relatively new anticancer drug. It is essential to find TDM-guided dosage for better safety and tolerability of patients. However, first, it is important to develop a suitable analyt
Externí odkaz:
https://doaj.org/article/d88f74306b6e406baae09e6342e10085
Autor:
Simona Biscarini, Davide Mangioni, Chiara Bobbio, Ludovica Mela, Laura Alagna, Sara Baldelli, Francesco Blasi, Ciro Canetta, Ferruccio Ceriotti, Andrea Gori, Giacomo Grasselli, Bianca Mariani, Antonio Muscatello, Dario Cattaneo, Alessandra Bandera
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Intravenous fosfomycin (IVFOF) is gaining interest in severe infections. Its use may be limited by adverse events (AEs). Little experience exists on IVFOF therapeutic drug monitoring (TDM) in real-life setting. Patients and method
Externí odkaz:
https://doaj.org/article/cba7b252968a40ce8c5ddc29fc62f793